Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China · Delayed Price · Currency is CNY 17.45
+0.85 (5.12%)
Jul 31, 2025, 2:45 PM CST
SHE:300519 Revenue
Zhejiang Xinguang Pharmaceutical had revenue of 93.25M CNY in the quarter ending March 31, 2025, a decrease of -7.26%. This brings the company's revenue in the last twelve months to 260.36M, down -6.56% year-over-year. In the year 2024, Zhejiang Xinguang Pharmaceutical had annual revenue of 267.66M, down -1.01%.
Revenue (ttm)
260.36M
Revenue Growth
-6.56%
P/S Ratio
10.79
Revenue / Employee
823.94K
Employees
316
Market Cap
2.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 267.66M | -2.74M | -1.01% |
| Dec 31, 2023 | 270.40M | -81.09M | -23.07% |
| Jan 1, 2023 | 351.49M | 30.61M | 9.54% |
| Jan 1, 2022 | 320.88M | 37.80M | 13.35% |
| Dec 31, 2020 | 283.08M | -8.18M | -2.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |